Cita APA

Gaibar Alonso, M., Novillo, A., Romero-Lorca, A., Malón, D., Antón, B., Moreno, A., & Fernández-Santander, A. (2022). FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer.

Citación estilo Chicago

Gaibar Alonso, María, Apolonia Novillo, Alicia Romero-Lorca, Diego Malón, Beatriz Antón, Amalia Moreno, y Ana Fernández-Santander. FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer. 2022.

Cita MLA

Gaibar Alonso, María, et al. FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer. 2022.